Search Results 1771-1780 of 17054 for monoclonal antibody
History of +VE test result indicating active hepatitis C or B (defined as both hepatitis B surface antigen and hepatitis core antibody +VE). Uncontrolled ...
... antibody (HBc Ab) positive (+) participants; HCV: HCV ribonucleic acid (RNA) detectable in any participant with anti-HCV antibody (HCV Ab). Patients with ...
... antibody-mediated rejection [ABMR]) and controls (no rejection histologically), <0.001 (receiver operating characteristic area under the curve [AUC], 0.74 ...
Recipients with Epstein-Barr virus (EBV) serostatus negative or unknown · History of acute rejection within 3 months prior to enrollment · History of antibody ...
... antibody targeting of proteins located around blood vessels. “I am truly honored, humbled and grateful to have been selected for this award,” says Dr ...
The vaccine works by causing your body to produce its own protection (antibodies) against the disease. It is also known as a "flu shot". Influenza is a ...
... Antibody Drug Conjugate, in Participants With Advanced ... antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma.
The vaccine works by causing your body to produce its own protection (antibodies) against the disease. Bexsero® and Trumenba® is active against group B ...
Positive patient anti-donor HLA antibody, which is deemed clinically significant. Prior allogeneic marrow or stem cell transplantation. Prior solid organ ...
quantitative IgM monoclonal protein > 1,000 mg/dL. ANC ≥ 1000/uL; Hgb ≥ 9 g/dl; PLT ≥ 75,000/uL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or if ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.